Viewing StudyNCT04459078



Ignite Creation Date: 2024-05-06 @ 2:52 PM
Last Modification Date: 2024-10-26 @ 1:39 PM
Study NCT ID: NCT04459078
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2022-12-02
First Post: 2020-06-29

Brief Title: Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma
Sponsor: Hunan Cancer Hospital
Organization: Hunan Cancer Hospital

Conditions & Keywords Data

Conditions:
Name
Adenocarcinoma of the Lung
Keywords:
Name View
immunotherapy View
PD-1 checkpoint inhibitor View
Anti-angiogenesis View
First-line Treatment View